Screener
Bausch Health Companies BHC Income Statement
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| $2.94B+9.7% | $2.85B+12.7% | $2.52B+11.7% | $2.8B+9.3% | $2.68B+6.8% | ||
| —— | —— | —— | —— | —— | ||
| $141M-15.1% | $173M+8.8% | $163M+14.0% | $161M-1.2% | $166M+13.7% | ||
| $834M+4.9% | $907M+1.5% | $861M-0.7% | $882M+7.6% | $795M-6.5% | ||
| $1.96B-5.0% | $2.11B+1.2% | $3.47B+75.2% | $2.32B+16.0% | $2.06B-5.9% | ||
| $983M+58.8% | $740M+66.7% | -$950M-444% | $474M-15.1% | $619M+94.7% | ||
| 33.4%+10.3pp | 25.9%+8.4pp | -37.6%-49.9pp | 17%-4.9pp | 23.1%+10.4pp | ||
| $398M-3.4% | $396M-14.8% | $402M+21.8% | $397M+17.8% | $412M+19.1% | ||
| -$1M+85.7% | -$7M+76.7% | -$11M-175% | -$11M+47.6% | -$7M— | ||
| $597M+174% | $348M+149% | -$1.35B-2,781% | $56M-73.2% | $218M+1,138% | ||
| $151M+308% | $88M+633% | $77M+97.4% | $159M+43.2% | $37M-47.9% | ||
| $436M+144% | $258M+74.3% | -$1.42B-2,353% | —— | $179M+311% | ||
| 14.8%+8.1pp | 9%+3.2pp | -56.4%-53.8pp | —— | 6.7%+10.1pp | ||
| $1.15+140% | $0.68+70.0% | -$3.82-2,287% | —— | $0.48+309% | ||
| $1.27B+37.0% | $1.02B+36.0% | -$655M-213% | $764M-11.7% | $925M+44.5% | ||
| 43.1%+8.6pp | 35.8%+6.1pp | -26%-51.7pp | 27.3%-6.5pp | 34.5%+9.0pp | ||
| $983M+58.8% | $740M+66.7% | -$950M-444% | $474M-15.1% | $619M+94.7% |
FAQ
- What is Bausch Health Companies's revenue?
- Bausch Health Companies (BHC) generated $11.1B in revenue over the trailing twelve months, up 10.8% year over year.
- What are Bausch Health Companies's profit margins?
- Gross margin is 71.4% and operating margin is 11.2%, with a -1.9% net margin.
- Where does Bausch Health Companies's income statement data come from?
- Every line is extracted from Bausch Health Companies's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
